UBS Group’s Vivani Medical, Inc. Warrants expiring 03/14/2024 VANIW Stock Holding History

UBS Group’s Portfolio VANIW Stock Details VANIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,562	Closed	-$1K	–	11685
2022 Q2	$1K	Buy	+4,562	New	+$1.44K	﹤0.01%	10199
2021 Q4	–	Sell	-2,952	Closed	-$2K	–	11179
2021 Q3	$2K	Buy	2,952 +2,937	+19,580%	+$2.58K	﹤0.01%	9091
2021 Q2	$0	Buy	+15	New	+$20	﹤0.01%	10158
2021 Q1	–	Sell	-1,776	Closed	–	–	9745
2020 Q4	$0	Buy	+1,776	New	+$202	﹤0.01%	8959
2020 Q1	–	Sell	-133	Closed	–	–	8602
2019 Q4	$0	Sell	133 -192	-59%	-$294	﹤0.01%	8553
2019 Q3	$1K	Buy	325 +286	+733%	+$519	﹤0.01%	7884
2019 Q2	$0	Buy	+39	New	+$66	﹤0.01%	8297
2018 Q2	–	Sell	-756	Closed	-$5K	–	8361
2018 Q1	$5K	Buy	+756	New	+$4.7K	﹤0.01%	7264

UBS Group's VANIW Position: Q3 2022 in Review

UBS Group sold out of Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) in Q3 2022, closing a stake of 4,562 shares — an estimated $1K sold.

UBS Group first reported a position in VANIW in Q1 2018 and held it in 8 quarters. The position peaked at $5K in Q1 2018. 0 funds tracked by Wall St. Rank hold VANIW as of Q3 2022.

UBS Group reported no remaining Vivani Medical, Inc. Warrants expiring 03/14/2024 position as of Q3 2022 after selling out during the quarter.
UBS Group sold 4,562 Vivani Medical, Inc. Warrants expiring 03/14/2024 shares in Q3 2022, an estimated $1K.
UBS Group first reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 in Q1 2018 and held it in 8 quarters.
UBS Group's Vivani Medical, Inc. Warrants expiring 03/14/2024 position peaked at $5K in Q1 2018.
0 funds tracked by Wall St. Rank held Vivani Medical, Inc. Warrants expiring 03/14/2024 as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.